Hyprevention Raises New Financing to Commercialize Spinal Implant

Hyprevention raised new financing to support U.S. launch of the V-STRUT© Vertebral Implant, indicated for use in the treatment of vertebral fractures. The company was granted a U.S. patent for the device in 2019, and FDA 510(k) clearance was granted in early 2020.

V-STRUT is made of INVIBIO PEEK Optima® polymer and is indicated to treat fractures in the thoracic and lumbar spine, used with Teknimed F20® bone cement.

Hyprevention has entered into a distribution agreement with DAWA Medical to sell the device in Florida, Illinois, Texas and Oklahoma.

“We are delighted that our existing investors have shown confidence in our product development efforts and commercialization plans for the US market by increasing their investment in the company,” says Cecile Vienney, CEO.